Autoactivation of prolegumain is accelerated by glycosaminoglycans

Biochimie

Volumn 95, Issue 4, 2013, Pages 772-781

  Berven, Lise ^a   Johansen, Harald Thidemann ^a   Solberg, Rigmor ^a   Kolset, Svein Olav ^a   Samuelsen, Anne Berit C ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Chondroitin sulphate; Glycosaminoglycan; Heparan sulphate; Heparin; Legumain

Indexed keywords

CARBOHYDRATES AND CARBOHYDRATE DERIVATIVES; CHONDROITIN 4 SULFATE; CHONDROITIN 4,6 SULPHATE; CHONDROITIN 6 SULFATE; CHONDROITIN SULFATE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARIN; LEGUMAIN; PROLEGUMAIN; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL INTERACTION; CHEMICAL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVATION; PH;

CYSTATIN M; CYSTEINE ENDOPEPTIDASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME PRECURSORS; GLYCOSAMINOGLYCANS; HEK293 CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; MOLECULAR WEIGHT; OSMOLAR CONCENTRATION; TIME FACTORS;

EID: 84874661939     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2012.11.002     Document Type: Article

References (54)

1. N.D. Rawlings, A.J. Barrett, and A. Bateman MEROPS: the database of proteolytic enzymes, their substrates and inhibitors Nucleic Acids Res. 40 2012 D343 D350
2. D.N. Li, S.P. Matthews, A.N. Antoniou, D. Mazzeo, and C. Watts Multistep autoactivation of asparaginyl endopeptidase in vitro and in vivo J. Biol. Chem. 278 2003 38980 38990
3. E. Dall, and H. Brandstetter Activation of legumain involves proteolytic and conformational events, resulting in a context- and substrate-dependent activity profile Acta Crystallogr. Sect. F. Struct. Biol. Cryst. Commun. 68 2012 24 31
4. S. Halfon, S. Patel, F. Vega, S. Zurawski, and G. Zurawski Autocatalytic activation of human legumain at aspartic acid residues FEBS Lett. 438 1998 114 118
5. M. Alvarez-Fernandez, A.J. Barrett, B. Gerhartz, P.M. Dando, J. Ni, and M. Abrahamson Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site J. Biol. Chem. 274 1999 19195 19203
6. J.M. Chen, P.M. Dando, N.D. Rawlings, M.A. Brown, N.E. Young, R.A. Stevens, E. Hewitt, C. Watts, and A.J. Barrett Cloning, isolation, and characterization of mammalian legumain, an asparaginyl endopeptidase J. Biol. Chem. 272 1997 8090 8098
7. R.V. Murthy, G. Arbman, J. Gao, G.D. Roodman, and X.F. Sun Legumain expression in relation to clinicopathologic and biological variables in colorectal cancer Clin. Cancer Res. 11 2005 2293 2299
8. J. Gawenda, F. Traub, H.J. Luck, H. Kreipe, and R. von Wasielewski Legumain expression as a prognostic factor in breast cancer patients Breast Cancer Res. Treat. 102 2007 1 6
9. J.M. Chen, M. Fortunato, R.A. Stevens, and A.J. Barrett Activation of progelatinase A by mammalian legumain, a recently discovered cysteine proteinase Biol. Chem. 382 2001 777 783
10. J. Mai, R.L. Finley Jr., D.M. Waisman, and B.F. Sloane Human procathepsin B interacts with the annexin II tetramer on the surface of tumor cells J. Biol. Chem. 275 2000 12806 12812
11. Y. Morita, H. Araki, T. Sugimoto, K. Takeuchi, T. Yamane, T. Maeda, Y. Yamamoto, K. Nishi, M. Asano, K. Shirahama-Noda, M. Nishimura, T. Uzu, I. Hara-Nishimura, D. Koya, A. Kashiwagi, and I. Ohkubo Legumain/asparaginyl endopeptidase controls extracellular matrix remodeling through the degradation of fibronectin in mouse renal proximal tubular cells FEBS Lett. 581 2007 1417 1424
12. S.J. Choi, S.V. Reddy, R.D. Devlin, C. Menaa, H. Chung, B.F. Boyce, and G.D. Roodman Identification of human asparaginyl endopeptidase (legumain) as an inhibitor of osteoclast formation and bone resorption J. Biol. Chem. 274 1999 27747 27753
13. S.J. Choi, N. Kurihara, Y. Oba, and G.D. Roodman Osteoclast inhibitory peptide 2 inhibits osteoclast formation via its C-terminal fragment J. Bone Miner. Res. 16 2001 1804 1811
14. L. Kjellen, and U. Lindahl Proteoglycans: structures and interactions Annu. Rev. Biochem. 60 1991 443 475
15. S.O. Kolset, and G. Pejler Serglycin: a structural and functional chameleon with wide impact on immune cells J. Immunol. 187 2011 4927 4933
16. B.G. Winchester Lysosomal metabolism of glycoconjugates Subcell. Biochem. 27 1996 191 238
17. J.C. Jacquinet, C. Lopin-Bon, and A. Vibert From polymer to size-defined oligomers: a highly divergent and stereocontrolled construction of chondroitin sulfate A, C, D, E, K, L, and M oligomers from a single precursor: part 2 Chemistry 15 2009 9579 9595
18. K. Prydz, and K.T. Dalen Synthesis and sorting of proteoglycans J. Cell. Sci. 113 Pt 2 2000 193 205
19. J.T. Gallagher, and A. Walker Molecular distinctions between heparan sulphate and heparin. Analysis of sulphation patterns indicates that heparan sulphate and heparin are separate families of N-sulphated polysaccharides Biochem. J. 230 1985 665 674
20. J.T. Gallagher, M. Lyon, and W.P. Steward Structure and function of heparan sulphate proteoglycans Biochem. J. 236 1986 313 325
21. R.V. Iozzo Matrix proteoglycans: from molecular design to cellular function Annu. Rev. Biochem. 67 1998 609 652
22. J.E. Silbert, and G. Sugumaran A starting place for the road to function Glycoconj. J. 19 2002 227 237
23. K. Sugahara, T. Mikami, T. Uyama, S. Mizuguchi, K. Nomura, and H. Kitagawa Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate Curr. Opin. Struct. Biol. 13 2003 612 620
24. S. Sarrazin, E. Adam, M. Lyon, F. Depontieu, V. Motte, C. Landolfi, H. Lortat-Jacob, D. Bechard, P. Lassalle, and M. Delehedde Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy Biochim. Biophys. Acta 1765 2006 25 37
25. J. Rozman, J. Stojan, R. Kuhelj, V. Turk, and B. Turk Autocatalytic processing of recombinant human procathepsin B is a bimolecular process FEBS Lett. 459 1999 358 362
26. D. Caglic, J.R. Pungercar, G. Pejler, V. Turk, and B. Turk Glycosaminoglycans facilitate procathepsin B activation through disruption of propeptide-mature enzyme interactions J. Biol. Chem. 282 2007 33076 33085
27. L. Mach, J.S. Mort, and J. Glossl Maturation of human procathepsin B. Proenzyme activation and proteolytic processing of the precursor to the mature proteinase, in vitro, are primarily unimolecular processes J. Biol. Chem. 269 1994 13030 13035
28. M. Beckman, C. Freeman, C.R. Parish, and D.H. Small Activation of cathepsin D by glycosaminoglycans FEBS J. 276 2009 7343 7352
29. O. Vasiljeva, M. Dolinar, V. Turk, and B. Turk Recombinant human cathepsin H lacking the mini chain is an endopeptidase Biochemistry 42 2003 13522 13528
30. K. Ishidoh, and E. Kominami Procathepsin L degrades extracellular matrix proteins in the presence of glycosaminoglycans in vitro Biochem. Biophys. Res. Commun. 217 1995 624 631
31. M. Fairhead, S.M. Kelly, and C.F. van der Walle A heparin binding motif on the pro-domain of human procathepsin L mediates zymogen destabilization and activation Biochem. Biophys. Res. Commun. 366 2008 862 867
32. R.W. Mason, and S.D. Massey Surface activation of pro-cathepsin L Biochem. Biophys. Res. Commun. 189 1992 1659 1666
33. O. Vasiljeva, M. Dolinar, J.R. Pungercar, V. Turk, and B. Turk Recombinant human procathepsin S is capable of autocatalytic processing at neutral pH in the presence of glycosaminoglycans FEBS Lett. 579 2005 1285 1290
34. P.C. Almeida, I.L. Nantes, J.R. Chagas, C.C. Rizzi, A. Faljoni-Alario, E. Carmona, L. Juliano, H.B. Nader, and I.L. Tersariol Cathepsin B activity regulation. Heparin-like glycosaminogylcans protect human cathepsin B from alkaline pH-induced inactivation J. Biol. Chem. 276 2001 944 951
35. Z. Li, W.S. Hou, C.R. Escalante-Torres, B.D. Gelb, and D. Bromme Collagenase activity of cathepsin K depends on complex formation with chondroitin sulfate J. Biol. Chem. 277 2002 28669 28676
36. K. Kubota, K. Wakabayashi, and T. Matsuoka Proteome analysis of secreted proteins during osteoclast differentiation using two different methods: two-dimensional electrophoresis and isotope-coded affinity tags analysis with two-dimensional chromatography Proteomics 3 2003 616 626
37. R. Smith, H.T. Johansen, H. Nilsen, M.H. Haugen, S.J. Pettersen, G.M. Maelandsmo, M. Abrahamson, and R. Solberg Intra- and extracellular regulation of activity and processing of legumain by cystatin E/M Biochimie 2012 10.1016/j.biochi.2012.1007.1026
38. H.T. Johansen, C.G. Knight, and A.J. Barrett Colorimetric and fluorimetric microplate assays for legumain and a staining reaction for detection of the enzyme after electrophoresis Anal. Biochem. 273 1999 278 283
39. A.J. Barrett, A.A. Kembhavi, M.A. Brown, H. Kirschke, C.G. Knight, M. Tamai, and K. Hanada L-trans-epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L Biochem. J. 201 1982 189 198
40. J. Hallgren, D. Spillmann, and G. Pejler Structural requirements and mechanism for heparin-induced activation of a recombinant mouse mast cell tryptase, mouse mast cell protease-6: formation of active tryptase monomers in the presence of low molecular weight heparin J. Biol. Chem. 276 2001 42774 42781
41. G. Pejler Lactoferrin regulates the activity of heparin proteoglycan-bound mast cell chymase: characterization of the binding of heparin to lactoferrin Biochem. J. 320 Pt 3 1996 897 903
42. S. Schedin-Weiss, U.R. Desai, S.C. Bock, S.T. Olson, and I. Bjork Roles of N-terminal region residues Lys11, Arg13, and Arg24 of antithrombin in heparin recognition and in promotion and stabilization of the heparin-induced conformational change Biochemistry 43 2004 675 683
43. L. Kozlowski Isoelectric Point Calculator 15 June 2012 http://isoelectric.ovh.org
44. A.D. Theocharis, M.E. Tsara, N. Papageorgacopoulou, D.D. Karavias, and D.A. Theocharis Pancreatic carcinoma is characterized by elevated content of hyaluronan and chondroitin sulfate with altered disaccharide composition Biochim. Biophys. Acta 1502 2000 201 206
45. C. Mizon, C. Mairie, M. Balduyck, E. Hachulla, and J. Mizon The chondroitin sulfate chain of bikunin-containing proteins in the inter-alpha-inhibitor family increases in size in inflammatory diseases Eur. J. Biochem. 268 2001 2717 2724
46. H. Lv, G. Yu, L. Sun, Z. Zhang, X. Zhao, and W. Chai Elevate level of glycosaminoglycans and altered sulfation pattern of chondroitin sulfate are associated with differentiation status and histological type of human primary hepatic carcinoma Oncology 72 2007 347 356
47. A.D. Theocharis Human colon adenocarcinoma is associated with specific post-translational modifications of versican and decorin Biochim. Biophys. Acta 1588 2002 165 172
48. A.I. Hashim, X. Zhang, J.W. Wojtkowiak, G.V. Martinez, and R.J. Gillies Imaging pH and metastasis NMR Biomed. 24 2011 582 591
49. P. Vaupel, F. Kallinowski, and P. Okunieff Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review Cancer Res. 49 1989 6449 6465
50. C. Liu, C. Sun, H. Huang, K. Janda, and T. Edgington Overexpression of legumain in tumors is significant for invasion/metastasis and a candidate enzymatic target for prodrug therapy Cancer Res. 63 2003 2957 2964
51. W. Wu, Y. Luo, C. Sun, Y. Liu, P. Kuo, J. Varga, R. Xiang, R. Reisfeld, K.D. Janda, T.S. Edgington, and C. Liu Targeting cell-impermeable prodrug activation to tumor microenvironment eradicates multiple drug-resistant neoplasms Cancer Res. 66 2006 970 980
52. T. Miyazaki, S. Miyauchi, A. Tawada, T. Anada, and O. Suzuki Effect of chondroitin sulfate-E on the osteoclastic differentiation of RAW264 cells Dent. Mater. J. 29 2010 403 410
53. S.S. Deepa, Y. Umehara, S. Higashiyama, N. Itoh, and K. Sugahara Specific molecular interactions of oversulfated chondroitin sulfate E with various heparin-binding growth factors. Implications as a physiological binding partner in the brain and other tissues J. Biol. Chem. 277 2002 43707 43716
54. Y. Furutani, R. Manabe, K. Tsutsui, T. Yamada, N. Sugimoto, S. Fukuda, J. Kawai, N. Sugiura, K. Kimata, Y. Hayashizaki, and K. Sekiguchi Identification and characterization of photomedins: novel olfactomedin-domain-containing proteins with chondroitin sulphate-E-binding activity Biochem. J. 389 2005 675 684